Shigeo Matsunaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shigeo Matsunaga has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Jo Sasame
Department of Neurosurgery, Yokohama Rosai Hospital, Yokohama, Japan
30 shared publications - Takashi Shuto
Department of Neurosurgery, Yokohama Rosai Hospital, Yokohama, Japan
29 shared publications - Hidetoshi Murata
Department of Neurosurgery, St. Marianna University School of Medicine, Kawasaki, Japan
28 shared publications - Akito Oshima
Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan
27 shared publications - Chihiro Oka
Department of Neurosurgery, Yokohama City University, Graduate School of Medicine, Yokohama, Japan
27 shared publications - Daniel P. Cahill
Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
27 shared publications
Latest Publications
- 1 October 2026
- Published by Springer Nature in Clinical Neuroradiology
- p. 1-11
Impact of Catheter-Induced Flow Compromise on the Presence of Multiple Ischemic Lesions in Endovascular Treatment of Posterior Circulation Aneurysms: A Two-Center Retrospective Study
Purpose Catheter-induced flow compromise (CFC) occurs during endovascular treatment of posterior circulation aneurysms; however, its embolic risk—particularly that of incomplete flow stasis as distinct from complete wedge—remains poorly characterized. We aimed to define CFC angiographically and evaluate its association, including subtype-specific effects, with multiple new ischemic lesions (MNIL) on postoperative diffusion-weighted imaging (DWI). Methods We retrospectively reviewed 108 patients treated for posterior circulation aneurysms at two institutions. CFC was defined angiographically as either flow stasis or wedge and was assessed independently by two blinded readers. Predictors of the primary outcome—multiple (≥ 3) new ischemic lesions on postoperative DWI—were identified by multivariable logistic regression adjusted for age, rupture status, and use of a double-catheter system. Results CFC occurred in 56.5% of patients and MNIL in 33.3%. Aneurysm rupture and CFC were independent predictors of MNIL (CFC: adjusted OR, 3.30; 95% CI, 1.18–9.23; p = 0.023), and both subtypes remained significant. The association was of similar magnitude when the eight patients managed with intraprocedural contralateral angiography were excluded (adjusted OR, 3.36; 95% CI, 1.20–9.44). Tortuosity at the vertebral artery origin was the principal predictor of CFC, and inter-rater agreement for CFC was almost perfect. Conclusion CFC was independently associated with MNIL in posterior circulation aneurysm embolization and occurred more frequently in patients with tortuosity at the vertebral artery origin, supporting preoperative assessment of vessel anatomy. Incomplete flow stasis carried a substantial embolic risk, warranting the same vigilance as wedge. Determining whether intraprocedural risk-avoidance strategies reduce the ischemic burden requires prospective evaluation.
- 1 October 2026
- Published by Springer Nature in Clinical Neuroradiology
- p. 1-11
Impact of Catheter-Induced Flow Compromise on the Presence of Multiple Ischemic Lesions in Endovascular Treatment of Posterior Circulation Aneurysms: A Two-Center Retrospective Study
Purpose Catheter-induced flow compromise (CFC) occurs during endovascular treatment of posterior circulation aneurysms; however, its embolic risk—particularly that of incomplete flow stasis as distinct from complete wedge—remains poorly characterized. We aimed to define CFC angiographically and evaluate its association, including subtype-specific effects, with multiple new ischemic lesions (MNIL) on postoperative diffusion-weighted imaging (DWI). Methods We retrospectively reviewed 108 patients treated for posterior circulation aneurysms at two institutions. CFC was defined angiographically as either flow stasis or wedge and was assessed independently by two blinded readers. Predictors of the primary outcome—multiple (≥ 3) new ischemic lesions on postoperative DWI—were identified by multivariable logistic regression adjusted for age, rupture status, and use of a double-catheter system. Results CFC occurred in 56.5% of patients and MNIL in 33.3%. Aneurysm rupture and CFC were independent predictors of MNIL (CFC: adjusted OR, 3.30; 95% CI, 1.18–9.23; p = 0.023), and both subtypes remained significant. The association was of similar magnitude when the eight patients managed with intraprocedural contralateral angiography were excluded (adjusted OR, 3.36; 95% CI, 1.20–9.44). Tortuosity at the vertebral artery origin was the principal predictor of CFC, and inter-rater agreement for CFC was almost perfect. Conclusion CFC was independently associated with MNIL in posterior circulation aneurysm embolization and occurred more frequently in patients with tortuosity at the vertebral artery origin, supporting preoperative assessment of vessel anatomy. Incomplete flow stasis carried a substantial embolic risk, warranting the same vigilance as wedge. Determining whether intraprocedural risk-avoidance strategies reduce the ischemic burden requires prospective evaluation.
- Open Access
- 1 January 2026
- Published by XMLink in Brain Tumor Research and Treatment
- Vol. 14 (2) , 57-65
Combined Surgical Strategy for Large Cystic Brain Metastases: A Case Series of Fractionated Stereotactic Radiotherapy With Cyst Drainage
Iwamoto K, et al. Brain Tumor Res Treat. 2026 Apr;14(2):57-65. https://doi.org/10.14791/btrt.2025.0040
- 1 January 2026
- Published by XMLink in Brain Tumor Research and Treatment
- Vol. 14 (2) , 57-65
Open AccessCombined Surgical Strategy for Large Cystic Brain Metastases: A Case Series of Fractionated Stereotactic Radiotherapy With Cyst Drainage
Iwamoto K, et al. Brain Tumor Res Treat. 2026 Apr;14(2):57-65. https://doi.org/10.14791/btrt.2025.0040
- Open Access
- 2 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Dose-Summation–Guided Re-irradiation Planning for Brain Metastases: Cross-Platform Verification Between Brainlab Elements and GammaPl
We report a practical, cross-platform workflow for cumulative-dose-aware re-irradiation in brain metastases. Before RT-DOSE is imported across planning systems (Brainlab Elements and/or GammaPlan), previously irradiated foci are treated prospectively as organs-at-risk during optimization, and the summed dose is visualized to avoid hotspots while preserving coverage. In a verification case planned without dose summation, a non-target previously irradiated focus ultimately developed radiation necrosis; post-hoc summation showed that explicit constraints could have reduced cumulative exposure. In a second case prospectively planned with summation, target coverage was maintained while decreasing the unintended dose to a non-target previously treated focus, with subsequent control and no new toxicity. This cross-platform approach is feasible and clinically actionable for balancing efficacy and safety during repeat stereotactic radiosurgery near prior high-dose regions.
- 2 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Open AccessDose-Summation–Guided Re-irradiation Planning for Brain Metastases: Cross-Platform Verification Between Brainlab Elements and GammaPl
We report a practical, cross-platform workflow for cumulative-dose-aware re-irradiation in brain metastases. Before RT-DOSE is imported across planning systems (Brainlab Elements and/or GammaPlan), previously irradiated foci are treated prospectively as organs-at-risk during optimization, and the summed dose is visualized to avoid hotspots while preserving coverage. In a verification case planned without dose summation, a non-target previously irradiated focus ultimately developed radiation necrosis; post-hoc summation showed that explicit constraints could have reduced cumulative exposure. In a second case prospectively planned with summation, target coverage was maintained while decreasing the unintended dose to a non-target previously treated focus, with subsequent control and no new toxicity. This cross-platform approach is feasible and clinically actionable for balancing efficacy and safety during repeat stereotactic radiosurgery near prior high-dose regions.
- Open Access
- 7 December 2024
- Published by Elsevier in World Neurosurgery
- Vol. 194, 123470
Diagnosis and Treatment of Cerebral Aneurysm Associated with Segmental Arterial Mediolysis: Our Experience and Systematic Review
- 7 December 2024
- Published by Elsevier in World Neurosurgery
- Vol. 194, 123470
Open AccessDiagnosis and Treatment of Cerebral Aneurysm Associated with Segmental Arterial Mediolysis: Our Experience and Systematic Review
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Mismatch ratio of genomic alterations in the prospective cohort
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Mismatch ratio of genomic alterations in the prospective cohort
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S4 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Summary of the retrospective cohort
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S4 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Summary of the retrospective cohort
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S7 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Genomic profiling of EGFR, PTEN, and TERT in IDH-wildtype lower-grade astrocytomas
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S7 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Genomic profiling of EGFR, PTEN, and TERT in IDH-wildtype lower-grade astrocytomas
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S5 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Illustrative mismatch cases in the prospective cohort
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S5 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Illustrative mismatch cases in the prospective cohort
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
IDH- and pTERT-wildtype gliomas at intraoperative integrated diagnosis in the retrospective cohort
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
IDH- and pTERT-wildtype gliomas at intraoperative integrated diagnosis in the retrospective cohort
- Open Access
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Fig. S1 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Single nucleotide detection threshold
- 5 January 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig. S1 from Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors
Single nucleotide detection threshold